These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23962786)

  • 1. High dose statins should be used in all patients undergoing percutaneous coronary intervention.
    Cay S; Durmaz T; Canpolat U; Aydogdu S
    Int J Cardiol; 2013 Oct; 168(5):5103-4. PubMed ID: 23962786
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
    Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
    Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Patti G; Leoncini M; Toso A; Maioli M; Grieco D; Colonna G; Bellandi F; Di Sciascio G
    Int J Cardiol; 2014 Jun; 174(2):440-1. PubMed ID: 24767765
    [No Abstract]   [Full Text] [Related]  

  • 4. Women are from SATURN and men are from an ASTEROID: deciphering the REVERSAL of coronary atheroma.
    Garcia-Garcia HM; Campos CM; Serruys PW
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):1023-4. PubMed ID: 25323164
    [No Abstract]   [Full Text] [Related]  

  • 5. Current statin usage for patients with acute coronary syndrome undergoing percutaneous coronary intervention: multicenter survey in Korea.
    Kim MJ; Jeon DS; Gwon HC; Kim SJ; Chang K; Kim HS; Tahk SJ;
    Clin Cardiol; 2012 Nov; 35(11):700-6. PubMed ID: 22825844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Saturn study].
    Fineschi M; Gaspardone A
    G Ital Cardiol (Rome); 2012; 13(7-8):469-73. PubMed ID: 22781373
    [No Abstract]   [Full Text] [Related]  

  • 7. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
    Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High coronary plaque load: a heavy burden.
    de Graaf MA; Jukema JW
    Eur Heart J; 2013 Nov; 34(41):3168-70. PubMed ID: 23966308
    [No Abstract]   [Full Text] [Related]  

  • 9. Statin wars: emphasis on potency vs event reduction and safety?
    Lavie CJ; Milani RV; O'Keefe JH
    Mayo Clin Proc; 2007 May; 82(5):539-42. PubMed ID: 17493417
    [No Abstract]   [Full Text] [Related]  

  • 10. Dyslipidaemia: Promising results for TA-8995 in TULIP.
    Mearns BM
    Nat Rev Cardiol; 2015 Aug; 12(8):443. PubMed ID: 26099844
    [No Abstract]   [Full Text] [Related]  

  • 11. The evolving role of CETP inhibition: beyond HDL cholesterol.
    Ray KK; Vallejo-Vaz AJ
    Lancet; 2015 Aug; 386(9992):412-4. PubMed ID: 26047976
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects and mechanisms of high loading dose rosuvastatin therapy before percutaneous coronary intervention in patients with acute coronary syndrome.
    Luo J; Li J; Shen X; Hu X; Fang Z; Lv X; Zhou S
    Int J Cardiol; 2013 Sep; 167(5):2350-3. PubMed ID: 23194788
    [No Abstract]   [Full Text] [Related]  

  • 13. First head-to-head study comparing rosuvastatin and atorvastatin effects on the treatment of atherosclerosis.
    Cardiovasc J Afr; 2008; 19(1):60. PubMed ID: 18320096
    [No Abstract]   [Full Text] [Related]  

  • 14. Temporal trends in the use of high-dose potent statins following acute coronary syndrome in Israel.
    Elis A; Pereg D; Dicker D; Gevrielov-Yusim N; Goldenberg I; Matetzky S; Kopel E; Klempfner R
    Cardiology; 2014; 128(3):266-72. PubMed ID: 24863615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive lipid intervention in the post-ENHANCE era.
    O'Keefe JH; Bybee KA; Lavie CJ
    Mayo Clin Proc; 2008 Aug; 83(8):867-9. PubMed ID: 18674470
    [No Abstract]   [Full Text] [Related]  

  • 16. Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.
    Kumar A; Cannon CP
    J Interv Cardiol; 2007 Dec; 20(6):447-57. PubMed ID: 18042049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin reloading before noncardiac surgery: a simple, safe and effective approach for reducing the risk of perioperative myocardial infarction.
    Colivicchi F
    Cardiology; 2015; 131(1):51-2. PubMed ID: 25871508
    [No Abstract]   [Full Text] [Related]  

  • 18. Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.
    Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
    Eur Heart J; 2013 Nov; 34(41):3182-90. PubMed ID: 23886915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of atorvastatin and rosuvastatin on oxidative stress in diabetic patients.
    Koksal M; Eren MA; Turan MN; Sabuncu T
    Eur J Intern Med; 2011 Jun; 22(3):249-53. PubMed ID: 21570643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
    Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.